Shanghai - Delayed Quote CNY
Zhejiang Ausun Pharmaceutical Co., Ltd. (603229.SS)
At close: October 18 at 3:00 PM GMT+8
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
12/31/2019
Cash Flows from Used in Operating Activities Direct
220,316.75
221,847.78
120,567.03
173,900.86
138,470.27
--
Operating Cash Flow
220,316.75
221,847.78
120,567.03
173,900.86
138,470.27
--
Investing Cash Flow
-162,899.92
-175,470.43
-177,846.98
-432,304.44
-105,441.20
--
Financing Cash Flow
-161,505.84
469,925.33
94,917.42
37,034.62
390,197.17
--
End Cash Position
972,662.06
1,088,001.59
563,746.69
488,928.45
720,930.07
--
Capital Expenditure
-168,623.68
-163,470.26
-271,913.86
-310,853.11
-92,954.94
--
Issuance of Debt
200,100.00
330,000.00
235,050.00
219,800.00
81,000.00
--
Repayment of Debt
-310,470.00
-271,700.00
-103,150.00
-151,000.00
-84,900.00
--
Free Cash Flow
51,693.07
58,377.52
-151,346.83
-136,952.24
45,515.33
--
12/31/2019 - 5/9/2017
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
2142.HK HBM Holdings Limited
1.260
+4.13%
6990.HK Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd.
193.000
+3.32%
2315.HK Biocytogen Pharmaceuticals (Beijing) Co., Ltd.
6.970
+5.45%
2616.HK CStone Pharmaceuticals
1.760
+8.64%
9688.HK Zai Lab Limited
21.800
+8.73%
1877.HK Shanghai Junshi Biosciences Co., Ltd.
14.460
+7.75%
1801.HK Innovent Biologics, Inc.
46.450
+3.57%